These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15259759)

  • 21. "Preservatives" in propofol.
    Craig DB
    Can J Anaesth; 1998 Sep; 45(9):913. PubMed ID: 9818119
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulfite supported lipid peroxidation in propofol emulsions.
    Baker MT; Dehring DJ; Gregerson MS
    Anesthesiology; 2002 Nov; 97(5):1162-7. PubMed ID: 12411802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propofol: an immunomodulating agent.
    Marik PE
    Pharmacotherapy; 2005 May; 25(5 Pt 2):28S-33S. PubMed ID: 15899746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the addition of lignocaine on propofol emulsion stability.
    Lilley EM; Isert PR; Carasso ML; Kennedy RA
    Anaesthesia; 1996 Sep; 51(9):815-8. PubMed ID: 8882240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jun; 54(11):1287-92. PubMed ID: 9179349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acidified propofol retains its anaesthetic potency after storage.
    Eriksson M; Englesson S; Hartvig P
    Eur J Anaesthesiol; 1999 Mar; 16(3):166-8. PubMed ID: 10225165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
    Nemec K; Germ E; Schulz-Siegmund M; Ortner A
    Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative propofol emulsion stabilities.
    Baker MT
    AANA J; 2000 Aug; 68(4):287. PubMed ID: 11125598
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4 degrees C.
    Chernin EL; Stewart JT; Smiler B
    Am J Health Syst Pharm; 1996 Jul; 53(13):1576-9. PubMed ID: 8809279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propofol: the challenges of formulation.
    Baker MT; Naguib M
    Anesthesiology; 2005 Oct; 103(4):860-76. PubMed ID: 16192780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.
    Damitz R; Chauhan A
    Int J Pharm; 2015; 486(1-2):232-41. PubMed ID: 25839419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
    Cai W; Deng W; Yang H; Chen X; Jin F
    Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging.
    Driscoll DF; Ling PR; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2007; 31(2):148-53. PubMed ID: 17308256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical compatibility of propofol with thiopental sodium.
    Prankerd RJ; Jones RD
    Am J Health Syst Pharm; 1996 Nov; 53(21):2606-10. PubMed ID: 8913389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Diprivan': a change of formulation.
    Hart B
    Eur J Anaesthesiol; 2000 Jan; 17(1):71-3. PubMed ID: 10798895
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol.
    Li G; Fan Y; Li X; Wang X; Li Y; Liu Y; Li M
    Int J Pharm; 2012 Apr; 425(1-2):53-61. PubMed ID: 22266535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging.
    Driscoll DF; Silvestri AP; Bistrian BR; Mikrut BA
    Am J Health Syst Pharm; 2007 Feb; 64(4):396-403. PubMed ID: 17299179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures.
    Driscoll DF; Bacon MN; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2000; 24(1):15-22. PubMed ID: 10638467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and efficacy of propofol containing EDTA: a randomised clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients.
    Zaloga GP; Teres D
    Intensive Care Med; 2000; 26 Suppl 4():S398-9. PubMed ID: 11310901
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid injectable emulsions: Pharmacopeial and safety issues.
    Driscoll DF
    Pharm Res; 2006 Sep; 23(9):1959-69. PubMed ID: 16951994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.